| Subcribe via RSS

Prognosis; it is a matter of life and death, How effective is that treatment?

Imagine a technology that reports the presence-severity-progression of any disease, the effectiveness of any treatment and the timing of non-acute death (we can’t tell you about oncoming buses). Well PrognostiCheck is it; we measure the phase angle which is an illustration of the vitality of cell membranes. Disease begins and ends on a cellular level. This level of the hierarchy of physiology occurs prior to where lab studies, imaging techniques and physicial examination come from so it takes (a little) work to understand it. However the results are a simple measured value; higher in health, lower in sickness, effective treatment stops it from lowering and causes it to rise. If your value goes below two degrees you die. hen you are diagnosed with a serious disese what your value is tells you if you will survive. The test is simple, inepxensive and noninvasive. It is precise (test, re-test reliabilit .99 out of 1) sensitive, specific and accurate (.98 out of 1).

If you are healthy it tells you how healthy you really are, did you recover from that injury or overcome your genetic heritage (the gift that keeps on giving). If you have one or more chronic diseases it tells you how frail you are, what the cumulative burden of the conditions that you have have done to you, if the treatment is working or do you (will you) have to do more. When you have a terminal condition it tells you about your death and enables you to make better end-of-life decisions.

The test is simple the implication enormous, let’s talk more!

Thank you,

Cheers!

Michaeal
IPGDx

Tags: , , , , , ,

Adenocarcinoma Prognosis

Adenocarcinoma is a carcinoma that begins in cells lining glandular types of internal organs (glandular epithelium tissue ) such as the lungs, breasts, colon, prostate, stomach, pancreas, and cervix and has gland-like properties.

PrognostiCheck® measures the prognosis of patients with Adenocarcinoma.

Check out the Slideshare Presentation on Adenocarcinoma Prognosis

View more presentations from IPGDx LLC.
Tags: , , , , , ,

Bioelectrical impedance Phase Angle as a Prognostic Indicator in advanced Pancreatic Cancer

Bioelectrical impedance analysis (BIA) is an easy-to-use, non-invasive and reproducible technique to evaluate changes in body composition and nutritional status. Phase angle, determined by BIA, has been validated for the assessment of body composition and nutritional status in a variety of patient populations including cancer patients.

The PrognostiCheck® device measures Phase Angle. Here is an abstarct from a study which investigated the prognostic role of phase angle in advanced pancreatic cancer.

The study investigated the prognostic role of phase angle in advanced pancreatic cancer. We evaluated a case series of fifty-eight stage IV pancreatic cancer patients treated at Cancer Treatment Centers of Americaw at Midwestern Regional Medical Center (Zion, IL, USA) between January 2000 and July 2003. BIA was conducted on all patients using a bioelectrical impedance analyser that operated at 50 kHz. The phase angle was calculated as capacitance (Xc)/resistance (R) and expressed in degrees. The Kaplan– Meier method was used to calculate survival. Cox proportional hazard models were constructed to evaluate the prognostic effect of phase angle independent of other clinical and nutritional variables. The correlations between phase angle and traditional nutritional measures were evaluated using Pearson and Spearman coefficients. Patients with phase angle ,5·08 had a median survival time of 6·3 (95 % CI 3·5, 9·2) months (n 29), while those with phase angle .5·08 had a median survival time of 10·2 (95 % CI 9·6, 10·8) months (n 29); this difference was statistically significant (P1⁄4 0·02)

In summary, this study has demonstrated the prognostic significance of the phase angle in advanced pancreatic cancer.

Tags: , , ,